Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$0.78 - $1.82 $3,527 - $8,231
4,523 Added 361.55%
5,774 $4,000
Q3 2023

Oct 30, 2023

BUY
$0.78 - $1.82 $3,527 - $8,231
4,523 Added 361.55%
5,774 $5,000
Q2 2023

May 21, 2024

SELL
$0.98 - $1.53 $28 - $44
-29 Reduced 2.27%
1,251 $1,000
Q2 2023

Jul 27, 2023

SELL
$0.98 - $1.53 $28 - $44
-29 Reduced 2.27%
1,251 $2,000
Q1 2023

May 21, 2024

BUY
$0.96 - $2.92 $307 - $934
320 Added 33.33%
1,280 $1,000
Q1 2023

Apr 27, 2023

BUY
$0.96 - $2.92 $307 - $934
320 Added 33.33%
1,280 $2,000
Q4 2022

May 21, 2024

BUY
$1.74 - $12.87 $1,670 - $12,355
960 New
960 $2,000
Q4 2022

Jan 31, 2023

BUY
$1.74 - $12.87 $139 - $1,029
80 Added 9.09%
960 $2,000
Q3 2022

Oct 21, 2022

BUY
$7.21 - $14.88 $6,344 - $13,094
880 New
880 $11,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $78.9M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.